Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2011 Oct 1.

Published in final edited form as: J Card Fail. 2010 Jun 16;16(10):835–842. doi: 10.1016/j.cardfail.2010.05.003

Table 1.

Patient demographics.

	Normal (n=14)	HF (n=33)
Gender (male / female)	10 / 4	30 / 3
Age (years)	52 ± 12	54 ± 8
Height (cm)	176.0 ± 9.0	174.9 ± 8
Weight (kg)	86.3 ± 15.7	86.6 ± 16.3
BMI (kg/m²)	27.9 ± 5.0	28.2 ± 4.3
Peak VO₂ (ml/min/kg)	33.2 ± 8.9	13.0 ± 3.8^*
NYHA Class (II / III / IV)	-	5 / 19 / 9
LVEF (%)	-	20 ± 6
Therapy Distribution:
Ace Inhibitors (%)	-	73
B-blockers (%)	-	85
Angiotensin II blocker (%)	-	18
Digitalis (%)	-	76
Diuretics (%)	-	91

BMI – body mass index; LVEF – left ventricle ejection fraction; NYHA – New York Heart Association; Peak VO₂ – peak oxygen consumption.

Data are presented as mean ± standard deviation.

^*

Significant differences between control and HF groups (p<0.01).